The disease-causing molecular mechanisms remain unknown, although inflammatory processes have been implicated by the identification of AMD susceptibility genes encoding complement factors (5, 6) and by the presence of complement proteins in drusen, the hallmark deposits associated with AMD and other features of immune activation, including inflammasome activation (7–10). The gene discussed is VTN; the disease is age-related macular degeneration.